Endogenous opioids and prenatal determinants of neuroplasticity

Advances in Experimental Medicine and Biology

Volumn 429, Issue , 1997, Pages 289-303

  Zagon, Ian S ^a   Tobias, Steven W ^a   McLaughlin, Patricia J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE DERIVATIVE; NALTREXONE; OPIATE AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BIRTH WEIGHT; BODY WEIGHT; CONTROLLED STUDY; GESTATIONAL AGE; GROWTH REGULATION; MOTOR DEVELOPMENT; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; STILLBIRTH;

ANIMALS; ANIMALS, NEWBORN; EMBRYONIC AND FETAL DEVELOPMENT; ENDORPHINS; FEMALE; HUMANS; NALTREXONE; NEURONAL PLASTICITY; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0031437386     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9551-6_21     Document Type: Article

References (55)

1. Akil, H.; Watson, S.J.; Young, E.; Lewis, M.E.; Katchaturian, H.; Walter, J.M. 1984. Endogenous opioids: Biology and function. Annu. Rev. Neurosci. 7:223-255.
2. Barg, J.; Belcheva, M.; McHale, R.; Levey, R; Vogel, Z.; Coscia, C.J. 1993. β-endorphin is a potent inhibitor of thymidine incorporation into DNA via μ- and κ-opioid receptors in fetal rat brain cell aggregates in culture. J. Neurochem. 60:765-767.
3. Bartolome, J.V.; Bartolome, M.B.; Lorber, B.A.; Dileo, S.S.; Schanberg, S.M. 1991. Effects of central administration of beta-endorphin on brain and liver DNA-synthesis in preweaning rats. Neuroscience 40:289-294.
4. Braude, M.C.; Morrison, J.M. 1976. Preclinical toxicity studies of naltrexone. NIDA Res. Monog. 9:16-26.
5. Clendeninn, N.J.; Petraitis, M.; Simon, E.J. 1976. Ontogological development of opiate receptors in rodent brain. Brain Res. 118:157-160.
6. Cohen, E.; Keshet, G.; Shavit, Y.; Weinstock, M. 1996. Prenatal naltrexone facilitates male sexual behavior in the rat. Pharmacol. Biochem. Behav. 54:183-189.
7. 3H]naloxone binding in rat brain. Neuropharmacology 15:555-560.
8. D'Amato, F.R.; Castellano, C.; Ammassari-Teule, M.; Oliverio, A. 1988. Prenatal antagonism of stress by naltrexone administration: Early and long-lasting effects on emotional behaviors in mice. Develop. Psychobiol. 21:283-292.
9. De Cabo, C.; Colado, M.I.; Pujol, A.; Martin, M.I.; Viveros, M.P. 1994. Naltrexone administration effects on regional brain monamines in developing rats. Brain Res. Bull. 34:395-406.
10. De Cabo de la Vega, C.; Pujol, A.; Viveros, M.P. 1995. Neonatally administered naltrexone affects several behavioral responses in adult rats of both genders. Pharmacol. Biochem. Behav. 50:277-286.
11. Diggle, P.J.; Liang, K.Y.; Zeger, S.L. 1994. Analysis of longitudinal data. Oxford: Clarendon Press.
12. Hall, C.S. Temperament: a survey of animal studies. Pyschol. Bull. 38:909-943; 1941.
13. Harry, G.J.; Rosecrans, J.A. 1979. Behavioral effects of perinatal naltrexone exposure: A preliminary investigation. Pharmacol. Biochem. Behav. 11 (Suppl.):19-22.
14. Hauser, K.F.; McLaughlin, P.J.; Zagon, I.S. 1989. Endogenous opioid systems and the regulation of dendritic growth and spine formation. J. Comp. Neurol. 281:13-22.
15. Hetta, J.; Terenius, L. 1980. Prenatal naloxone affects survival and morphine sensitivity of rat offspring. Neurosci. Letts. 16:323-327.
16. Kashon, M.L.; Ward, O.B.; Grisham, W.; Ward, I.L. 1992. Prenatal β-endorphin can modulate some aspects of sexual differentiation in rats. Behav. Neurosci. 106:555-562.
17. Keshet, G.I.; Weinstock, M. 1995. Maternal naltrexone prevents morphological and behavioral alterations induced in rats by prenatal stress. Pharmacol. Biochem. Behav. 50:413-419.
18. Knodel, E.L.; Richelson, E. 1980. Methionine-enkephalin immuno-reactivity in fetal rat brain cells in aggregating culture and in mouse neuroblastoma cells. Brain Res. 197:565-570.
19. Leng, G.; Mansfield, S.; Bicknell, R.J.; Dean, A.D.P.; Ingram, C.D.; Marsh, M.I.C.; Yates, J.O.; Dyer, R.G. 1985. Central opioids: A possible role in parturition? J. Endocrinol. 106:219-224.
20. Mayer, A.D.; Faris, P.L.; Komisaruk, B.R.; Rosenblatt, J.S. 1985. Opiate antagonism reduces placentophagia and pup cleaning by parturient rats. Pharmacol. Biochem. Behav. 22:1035-1044.
21. McLaughlin, P.J. 1994. Opioid antagonist modulation of rat heart development. Life Sci. 54:1423-1431.
22. 5]-enkephalin. Am. J. Physiol. 271:R122-R129.
23. McLaughlin, P.J.; Tobias, S.W.; Lang, C.M.; Zagon, I.S. 1997a. Chronic exposure to the opioid antagonist naltrexone during pregnancy: Maternal and offspring effects. Physiol. Behav., in press.
24. McLaughlin, P.J.; Tobias, S.W.; Lang, C.M.; Zagon, I.S. 1997b. Opioid receptor blockade during prenatal life modifies postnatal behavioral development. Pharmacol. Biochem. Behav., in press.
25. Meriney, S.D.; Ford, M.J.; Oliva, D.; Pilar, G. 1991. Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J. Neurosci. 11:3705-3717.
26. Monder, H.; Yasukawa, N.; Christian, J.J. 1979. Perinatal naloxone: When does naloxone affect hyperalgesia? Pharmacol. Biochem. Behav. 11:235-237.
27. Murgo, A.J. 1985. Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J. Natl. Cancer Inst. 75341-344.
28. Najam, N.; Panksepp, J.. 1989. Effect of chronic neonatal morphine and naloxone on sensorimotor and social development of young rats. Pharmacol. Biochem. Behav. 33:539-544.
29. Neale, J.H.; Barker, J.L.; Uhl, G.R.; Snyder, S.H. 1979. Enkephalin-containing neurons visualized in spinal cord cultures. Science 201:467-469.
30. Nieder, G.L; Corder, C.N. 1982. Effects of opiate antagonists on early pregnancy and pseudopregnancy in mice. J. Reprod. Fert. 65:341-346.
31. Pfeiffer, D.G.; Nikolarakis, K.E.; Pfeiffer A. 1984. Chronic blockade of opiate receptors: Influence on reproduction and body weight in female rats. Neuropeptides 5:279-282.
32. Sandman, C.A.; Yessaian, N. 1986. Persisting subsensitivity of the striatal dopamine system after fetal exposure to beta-endorphin. Life Sci. 39: 1755-1763.
33. Seatriz, J.V.; Hammer, R.P. 1993. Effects of opiates on neuronal development in the rat cerebral cortex. Brain Res. Bull. 30:523-527.
34. + murine T cells. J. Pharmacol. Exp. Ther. 273:1105-1113.
35. Shepanek, N.A.; Smith, R.F.; Anderson, L.A.; Medici, C.N. 1995. Behavioral and developmental changes associated with prenatal opiate receptor blockade. Pharmacol. Biochem. Behav. 50:313-319.
36. Shepanek, N.A.; Smith, R.F.; Tyer, Z.; Royall, D.; Allen, K. 1989. Developmental, behavioral, and structural effects of prenatal opiate receptor blockade. New York Acad. Sci. 562:377-379.
37. Villiger, P.M.; Lotz, M. 1992. Expression of prepro-enkephalin in human articular chondrocytes is linked to cell proliferation. EMBO J. 11:135-143.
38. Vorhees, C.V. 1981. Effects of prenatal naloxone exposure on postnatal behavioral development of rats. Neurobehav. Toxicol. Teratol. 3:295-301.
39. Ward, O.B.; Monaghan, E.P.; Ward, I.L. 1986. Naltrexone blocks the effects of prenatal stress on sexual behavior differentiation in male rats. Pharmacol. Biochem. Behav. 25:573-576.
40. Werboff, J.; Havlena, H.; Sikov, M.R. 1962. Effects of prenatal X-irradiation on activity, emotionality, and maze-learning ability in the rat. Radiat. Res. 16:441-452.
41. Zadina, J.E.; Kastin, A.J.; Coy, D.H.; Adinoff, B.A. 1985. Developmental, behavioral, and opiate receptor changes after prenatal or postnatal β-endorphin, CRF, or Tyr-MIF-I. Psychoneuroendocrinology 10:367-383.
42. 5]-enkephalin) prevents the incidence and retards the growth of human colon cancer. Am. J. Physiol. 271:R780-R786.
43. Zagon, I.S.; Hytrek, S.D.; McLaughlin, P.J. 1996b. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am. J. Physiol. 271:R511-R518.
44. Zagon, I.S.; McLaughlin, P.J. 1983a. Increased brain size and cellular content in infant rats treated with opiate antagonist. Science 221:1179-1180.
45. Zagon, I.S., McLaughlin, P.J. 1983b. Naltrexone modulates tumor response in mice with neuroblastoma. Science 221:671-673.
46. Zagon, I.S.; McLaughlin, P.J. 1983c. Naltrexone modulates growth in infant rats. Life Sci. 33:2449-2454.
47. Zagon, I.S.; McLaughlin, P.J. 1984. Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth. Life Sci. 35:2057-2064.
48. Zagon, I.S.; McLaughlin, P.J. 1985a. Naltrexone's influence on neurobehavioral development. Pharmacol. Biochem. Behav. 22:441-448.
49. Zagon, I.S.; McLaughlin, P.J. 1985b. Opioid antagonist-induced regulation of organ development. Physiol. Behav. 34:507-511.
50. Zagon, I.S.; McLaughlin. P.J. 1989. Naloxone modulates body and organ growth of rats: Dependency on the duration of opioid receptor blockade and stereospecificity. Pharmacol. Biochem. Behav. 33:325-328.
51. Zagon, I.S.; McLaughlin, P.J. 1991a. The role of endogenous opioids and opioid receptors in human and animal cancers. In: Plotnikoff, N.P.; Murgo, A.J.; Faith, R.E.; Wybran, J., eds. Stress and Immunity, Caldwell, NJ:CRC, pp. 343-356.
52. Zagon, I.S.; McLaughlin, P.J. 1991b. Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res. 542:318-323.
53. Zagon, I.S.; McLaughlin, P.J. 1993. Opioid growth factor receptor in the developing nervous system. In: Zagon, I.S.; McLaughlin, P.J., eds. Receptors in the Developing Nervous System. Growth Factors and Hormones. Volume 1. London:Chapman and Hall, pp. 39-62.
54. Zagon, I.S.; McLaughlin, P.J.; Thompson, C.I. 1979. Development of motor activity in young rats following perinatal methadone exposure. Pharmacol. Biochem. Behav. 10:743-749.
55. Zagon, I.S.; Sassani, J.W.; McLaughlin, P.J. 1995. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture. Am. J. Physiol. 268:R942-R950.